Periarteritis/periaortitis y fibrosis retroperitoneal en enfermedad relacionada por IgG4
Keywords:
enfermedad relacionada a IgG4, IgG4, aortitis, periaortitisAbstract
La enfermedad relacionada a IGg4 es una afección fibroinflamatoria sistémica que cobra cada vez más relevancia. Se caracteriza por una triada clásica en el análisis histopatológico: Infiltrado Linfoplasmocitario, Fibrosis Estoriforme y Flebitis obliterante. El compromiso cardiovascular no queda fuera de su espectro pudiendo afectar a las arterias coronarias, las válvulas cardíacas, el miocardio, el pericardio, la aorta y la vasculatura periférica, confundiéndose con otras entidades reumatológicas que cursan con este compromiso. Resulta entonces fundamental reconocer las características clínicas e imagenológicas que la diferencian de las demás etiologías inflamatorias para su sospecha clínica y un óptimo accionar evitando complicaciones potencialmente fatales.
La existencia de nuevos criterios órgano específicos pueden facilitar el diagnóstico de dicho compromiso. La afección vascular asociado con IgG4 puede causar complicaciones potencialmente mortales, como ruptura de aneurismática y estenosis arterial; sin embargo, los detalles de las características clínicas, el pronóstico y el tratamiento óptimo siguen sin ser claros debido a la rareza de esta afección.
Downloads
References
Floreani y col. IgG4-Related desase: Changing epidemiology and new thoughts on a multisystem desase. J Transl Autoimmun. 2021; 4: 10074.
- Mizushima I, Kasashima S, Fujinaga col. IgG4 related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening. Mod Rheumatol 2019;29(2): 240-250.
- Jennette JC, Falk RJ, Bacon PA col. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitis. Arthritis Rheum 2013;65(1):1-11.
- Misawa Y. Immunoglobulin G4-Related Cardiovascular Diseases. Ann Thorac Cardiovasc Surg 2017; 23: 281–285
-Palmisano A, et al. Chronic periaortitis: an update. Curr Rheumatol Rep. 2018;20(12):80. doi: 10.1007/s11926-018-0789-2.
- DI Walker, K Bloor, G Williams, I Gillie, Aneurismas inflamatorios de la aorta abdominal, British Journal of Surgery, volumen 59, número 8, agosto de 1972, páginas 609–614.
- Kasashima S, Zen Y, Kawashima A, et al. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vac. Surg 2008;49(5):1264-1271.
- Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2009;32(2):197-204.
-Kasashima S, Zen Y, Kawashima A, et al. A clinicopathologic study of Immunoglobulin IgG4-related sclerosing disease of the thoracic aorta. J Vac. Surg 2010;52(6):1587-1595.
-Stone JH, Khosroshahi A, Deshpande V et al. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthitis Care Res. 201 ;62:316-322.
-Stone JH, Khosroshahi A, Hilgenberg A. IgG4-related systemic disease and lymphoplasmocytic Aortitis. Arthritis Rheum 2009;60:3139-3145.
- Koo BS, Koh YW, Hong S, et al. Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises. Int J Rheum Dis. 2014;17(4):420-424.
- Inoue D, Zen I, Abo H et al. immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology 2011; 261:625-633.
- Ozawa y col. Clinical features of IgG4-related periaortitis/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case–control study. 2017.
-Peng L, Zhang P, Li J col. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Research therapy.2020, 22;103:1-11.
-Kim IY, Eun YH, Jeong H Col. Clinical Characteristic and outcomes of 61 patients with chronic periaortitis including IgG4 Related and non IgG4 related cases. Int J Rheum Dis 2017;20(11):1751-1762.
-Perugino CA y col. Large vessel involvement by IgG4-related disease. Medicine (Baltimore) 2016;95,28:1-11 .
-Dong A, Wang Y, Zuo C. FDG PET/CT in IgG4-Related Peripulmonary Arteritis. Clin Nucl Med. 2016;41(10):e439–40.
-Sakamoto A, Nagai R, SaitoK col. Idiophatic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis-retrospective analysis of 11 cases histories. J Cardiol 2012;59(2)139-146.
-Umehara y cols. Comprehensive diagnostic criteria for IgG4 related disease. Mod Rheumatol.2012 Feb;22(1):21-30
- Mizushima I, Kasashima S, Fujinaga col. Clinical and Pathological characteristic of IgG4 related periaortitis/periarteritis and Retroperitoneal Fibrosis Diagnosed Based on Experts’ Diagnosis. Ann Vasc Dis 2019;12(4):460-472.
- Zen Y, Nakanuma Y. IgG4-related disease: a cross sectional study of 114 cases. Am J Surg Pathol. 2010; 34:1812-1819.
- Martin Nares E. et al. Enfermedad relacionada a IgG4: una entidad multifacética. Revista Médica MD 2016:7:156-169.
- Wallace ZS, Zhang Y, Perugino C et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 2019; 78:406-412.
-Lanzillota M, Corrado Campochiaro, Gaia Mancuso col. Clinical phenotypes of IgG4-related reflect different prognostic outcomes. Rheumatology 2020.
-Nares M, Baenas D, Cuellar Gutierrez M et al. Clinical and serological features in Latin-American IgG4-related disease patients differ according to sex, Ethnicity, and clinical phenotype. J. Clin Rheum 2022.
-Fernandez-Codina A, Pinilla B, Pinal-Fernandez l col. Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical Phenotypes in a Spanish multicenter registry (REERIGG4) Rheumatology 2021;60:217-223.
-Akiyama M, Kaneko Y, Takeuchi T. Characteristic and prognosis of IgG4-related periaortitis/periarteritis: A systematic literature review. Autoimmunity Rev 2019:18(10):381-392.
- Emma L Culver et al. Elevated serum IgG4 levels in Diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-Related Disease UK Cohort. Am J Gastroenterol. 2016.
-Manobe N, Yabusaki S, Manabe O col.IgG4-related cardiovascular disease from de Aorta to the Coronary arteries: Multidetector CT and PET/CT. Radiographic 2018; 38:1934-1948.
-Kim YW, Sung K, Park YJ, et al. Surgical treatment of middle aortic syndrome due to Takayasu arteritis. J Vasc Surg.2015;62:750-751.
-Schmidt W, Nielsen B. Imaging in Large-vessel vasculitis. Best Pract. Res. Clin. Rheumatol 2020
-Zen, Y, Onodera M, Inoue D et al retroperitoneal fibrosis: a clinicopathologic with respect to immunoglobulin G4. American J Surg Pathol.2009 ;33:1833-1839.
-Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm, spectrum of IgG4-related chronic periaortitis. Ann Vasc Dis 2010;3:182-189.
-Schmidt W et al. Imaging in large-vessel vasculitis. Best practice and research clinical rheumatology. 2020.
-Yamamoto H, Sugiyama E, Serikawa M, et al. Clinical features and predictive value of serum inflammatory markers of perivascular involvement in immunoglobulin G4-related disease. Heart Vessel. 2017;32(10):1176–1185. doi: 10.1007/s00380-017-0987-2.
- Kasashima S, Kawashima A, Kasashima F, Endo M, Matsumoto Y, Kawakami K. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessel. 2018;33(12):1471–1481. doi: 10.1007/s00380-018-1203-8.
-Anita S y Chan. Et al. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4 Related Disease: Potential use in IgG4-RD assessment. Br J Opthalmol. 2017.
-Mizushima I, Kasashima S, Notahara K et al. Clinical and pathological characteristic of IgG4 related periaortitis/periarteritis and retroperitoneal fibrosis diagnosed based on experts’ diagnosis. J Jpn Coll Angiol 2018; 58:117-119.
-Umehara H, Okasaki K, Kawano M col. How to diagnose IgG4-Related Disease. Ann Rheum Dis 2017.
-Ishizaka N, Fujinaya Y,Hourai R et al. Prevalence of elevated serum IgG4level among patients diagnoses or suspected cardivascular disorders. J Jpn Coll Angiol 2017;57:91-98.
- Khosroshahi A, Wallace Z, Crowe J.L col. International Consensus Guidance Statement on the Management and treatment of IgG4-Related Disease. Arthritis Rheum 2015;67(7):1688-1699.
-Jorie Buijs 1, Marianne J van Heerde, Erik A J Rauws et al. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis. Pancreas. 2014 Mar;43(2):261-7.
-Qingjun Wu, Jie Chang, et.al. Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial. Int J Rheum Dis. 2017 May;20(5):639-646.
-Yunyun F, Yu P, Panpan Z, et al. Efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Rheumatology (Oxford) 2019;58(1):52–60. doi: 10.1093/rheumatology/key227.
-Binder M, Uhl M, Wiech T, et al. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis. 2012;71(2):311–312. doi: 10.1136/annrheumdis-2011-200148.
- Yunyun F, Yu C, Panpan Z, et al. Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep. 2017;7(1):6195. doi: 10.1038/s41598-017-06520-5
-Loricera J, Blanco R , Castaneda S et al. Tocilizumab in refractory aortitis: study on 16 patients and literatura review. Clin Exp. Rheumatol 2014;32: S79-89.
-Vaglio A, Catanoso MG, Spaggiari L et al. Interleukin-6 as an inflammatory mediator and target of therepy in chronic periaortitis. Arthritis Rheum 2013; 65:2469-2475.
-Sanges S, Riviere S, Mekinian A et al. Intravenous Immunoglobulins in systemic sclerosis: data from a French nationwide cohort of 46 patients and review of the literature. Autoimmun Rev 2017;16:377-384.
- Wang M, Zhang P, Lin W, et al. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy. Arthritis Res Ther. 2019;21(1):44. doi: 10.1186/s13075-019-1828-8.
Downloads
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
